Fluoroscopy Market

Global Fluoroscopy Market Size (2023 to 2028)

The global fluoroscopy market is estimated to grow at a CAGR of 3.2% during the forecast period. As a result, the market size is estimated to be USD 2480 million by 2028 from USD 2119 million in 2023.

Global Fluoroscopy Market Share Insights:

• Based on surgery type, the cardiovascular interventions segment had the major share of the global market in 2022.
• Based on end-user, the hospital segment held the leading share of the market in 2022.
• The North American region was the largest regional segment in the worldwide market and accounted for the dominating share of the market in 2022.
• The European region held a notable share of the worldwide market in 2022. 

It is primarily used to image the gastrointestinal tract to analyze clinical conditions, for example, tumors, ulcers, irritation, etc. It can likewise be utilized to screen the methods, for example, angiography, venography, orthopedic surgeries, and situation of peritoneal catheters, certain biopsies, and numerous other surgical techniques that require radiological medication.

The growing number of partnerships and merging activities between the market participants is propelling the fluoroscopy market growth. The growing usage of fluoroscopy techniques and the growing need for high-end healthcare infrastructure in developing and underdeveloped nations are favoring the worldwide fluoroscopes market growth.

However, the growing usage of refurbished devices and the low substitution rate of fluoroscopes are hindering the growth rate of the worldwide fluoroscopes market.

REPORT COVERAGE:

This research report on the global fluoroscopy market segmented and sub-segmented into the following categories.

Fluoroscopy Market - By Surgery Type

• Cardiovascular interventions
• Biopsy
• Orthopedic surgeries
• Others

Fluoroscopy Market - By End User

• Hospitals
• Diagnostic centers
• Clinics

Fluoroscopy Market - By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Geographically, the fluoroscopy market in North America is projected to lead the global market during the forecast period. The continuous rise in the number of patients suffering from CVDs is one of the major factors propelling the market growth in the North American region. In addition, the growing aging population and well-established healthcare infrastructure are promoting the regional market growth. Furthermore, the presence of key market participants and developed economies favor the fluoroscopy market in this region. The U.S. dominated the market in 2021 and is anticipated to continue the dominating trend throughout the forecast period owing to the growing population suffering from heart diseases. According to the statistics published by the Centers for Disease Prevention and Control (CDC), an estimated 647,000 Americans die from heart disease yearly, one person every 37 seconds.

The Asia Pacific fluoroscopy market is one of the potential regional markets worldwide and is estimated to showcase the fastest CAGR in the coming years. Factors such as the presence of developing economies, increasing adoption of fluoroscopy by hospitals, and rising awareness regarding the advantages of using fluoroscopy promote regional market growth. In addition, the growing number of road accidents and continuous growth in the region’s population is contributing to the growth of the APAC fluoroscopy market. In the recent past, APAC countries such as India, China, and Japan have accounted for the most significant share of the regional market.

The European fluoroscopy market is anticipated to grow at a promising CAGR during the forecast period.

The fluoroscopy market in Latin America is estimated to hold a considerable share of the worldwide market during the forecast period.

The MEA fluoroscopy market is expected to grow at a moderate CAGR in the coming years.

KEY MARKET PARTICIPANTS:

Companies leading the global fluoroscopy market profiled in the report are GE Healthcare., Orthoscan Inc., Hologic Inc., Shimadzu Corporation, Siemens Medical Solutions, Philips N.V., Hitachi Ltd., Toshiba Medical Systems Corporation, Ziehm Imaging GmbH, and Amico X-ray innovations.